An international project to create a "digital twin" of the human immune system could help scientists finally tackle grand ...

Predictive model accelerates the development of nanoparticles as potential drug carriers for targeting neurodegenerative ...

This year’s summit provides a platform for an outstanding group of researchers, evangelists and entrepreneurs to showcase the latest advances, applications and challenges regarding the deployment of ...

"Organoids are set to become essential tools in medical research. The research program financed by SATT AxLR and the support of CTIBIOTECH, in this key stage, will enable Cilcare to accelerate the ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...

With support from EDB and A*Star, Japanese biopharma leader Chugai is using its research base in Singapore to create new ...

For decades, animal models have been the gold standard for preclinical testing of potential drugs. Yet, even the best animal models are not perfect. For example, small rodent species with engrafted ...

MISSOULA, Mont. — A cancer-treatment compound (INI-4001), developed by the University of Montana in partnership with Inimmune Corp., is heading to Phase I human clinical trials. Previously, in animal ...